Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 13 May 2019 for Trevi Therapeutics, Inc..
Insider track record
Disclosed buys
9
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter F. Drake: trading record in brief
Filings by Peter F. Drake span 5 companies, the busiest being Penwest Pharmaceuticals Co, Enthrust Financial Services Inc and Navidea Biopharmaceuticals, Inc. Over a trading history stretching from 3 January 2006 to 9 May 2019, the count stands at 53 filings.
No open-market sale appears; the market trades are 9 purchases worth €230k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 41 share grants.
The median purchase comes to €17k.
The newest entry dates from 13 May 2019: a transaction, in Trevi Therapeutics, Inc. The most recent open-market purchase was published on 18 October 2011, 5,484 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Peter F. Drake
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
62,540 sharesCommon StockSEC:0000899243-19-013263:0
22,000 shares0Common StockSEC:0001144204-15-019364:0
7,606 shares@ US$1.89Common StockSEC:0001144204-15-006981:0
10,973 shares@ US$1.32Common StockSEC:0001144204-14-066987:0
20,000 shares0Common StockSEC:0001225208-14-004932:0
12,250 shares0Common StockSEC:0001225208-13-005552:0
17,000 shares0Common StockSEC:0001225208-12-009631:0
10,000 shares@ US$3.08Common StockSEC:0001225208-11-023478:0
Canonical exit: 14 Dec 2011 (T+90)
10,000 sharesCommon StockSEC:0000930413-11-003754:0
100,263 sharesCommon StockSEC:0001209191-10-047265:0
2,240 shares@ US$3.46Common StockSEC:0001209191-10-020674:0
100 shares@ US$2.50Common StockSEC:0001209191-10-011034:0
6,000 shares0Common StockSEC:0001209191-10-000938:0
2,662 shares@ US$2.63Common StockSEC:0001209191-10-000938:1
30,000 sharesCommon StockSEC:0000930413-09-005509:0
3,286 shares@ US$2.13Common StockSEC:0001209191-09-047263:0
2,536 shares0Common StockSEC:0001209191-09-034852:0
12,000 shares0Common StockSEC:0001209191-09-022098:0
4,000 shares0Common StockSEC:0001209191-09-020288:0
4,192 shares0Common StockSEC:0001209191-09-001123:0
6,000 shares0Common StockSEC:0001209191-09-001123:1
1,705 shares0Common StockSEC:0001209191-08-060675:0
9,768 sharesCommon StockSEC:0000930413-08-006202:0
3,955 shares0Common StockSEC:0001209191-08-054491:0
346 shares0Common StockSEC:0001209191-08-051257:0
25 of 52 declarations
